nausea and vomiting during cesarean section under spinal anesthesia. Other complications of spinal and epidural anaesthesia during labour and delivery
Conditions
Interventions
Intervention 1: In group 1 or placebo(Control) postdelivery, first normal saline iv injected, then infusion of NNormal salin establish until the end of surgery. Intervention 2: In group 2 or Interven
Treatment - Drugs
In group 1 or placebo(Control) postdelivery, first normal saline iv injected, then infusion of NNormal salin establish until the end of surgery.
In group 2 or Intervention post delivery, first propofol 20 mg intravenous injected, then infusion of propofol 1 mg/kg/h established until the end of surgery.
In group 3 or Midazolam post delivery, Midazolam 1 mg bulos intravenous injected, then infusion of Midazolam 1 mg/kg/h established until the end of surgery.
Sponsors
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: ]Inclusion criteria:Elective cesarean, phisical status of class ASA 1 and 2, age 20-30 years Exclusion criteria: Gastrointestinal disease, history of management with anti emetic drugs in the past 24 h, patients who spinal anesthesia has cnterindication
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: after spinal anesthesia until 6 h. Method of measurement: the intencity of nausea and vomiting with Bellville score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: the baseline of BP, after spinal anesthesia every 2 minute until 15 min, then every 5 min until the end of operation. Method of measurement: noninvasive by new tech monitoring set.;Sedation. Timepoint: In the end of operation. Method of measurement: With using of Modified Ramcy sedation scoring.;Total ephedrine consumption. Timepoint: In the end of operation. Method of measurement: Ephedrine consumption (mg). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Sousan Rasooli
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Outcome results
None listed